Notably, silencing of SIX1, using two independent shRNAs, led to a marked reduction in SOX2 transcript and protein in both glioma cell lines, in line with the results in mouse transformed fibroblasts (Fig. 6a,b). The gene discussed is SOX2; the disease is central nervous system cancer.